Impact of minimal residual disease (MRD) in salvage autologous stem cell transplantation for relapsed myeloma: results from the NCRI Myeloma X (intensive) trial

Bone Marrow Transplantation, Published online: 09 January 2024; doi:10.1038/s41409-023-02164-4Impact of minimal residual disease (MRD) in salvage autologous stem cell transplantation for relapsed myeloma: results from the NCRI Myeloma X (intensive) trial

Source: Bone Marrow Transplantation - January 9, 2024 Category: Hematology Authors: Ruth M. de Tute Gordon Cook David A. Cairns Julia M. Brown Jamie Cavenagh A. John Ashcroft John A. Snowden Kwee Yong Eleni Tholouli Matthew Jenner Anna Hockaday Mark T. Drayson Treen C. M. Morris Andy C. Rawstron Roger G. Owen Source Type: research